Tool reference

36 tools across 12 datasets. Each is callable over MCP (tools/call) and most have a REST mirror. Click any tool for its parameters, credit cost, and runnable examples.

Capital rotation#

capital_rotation12 crTHE flagship 'where is smart money rotating' signal. Aggregates quarter-over-quarter SEC 13F position changes across ALL tracked institutions into per-SECTOR capital flows: which sectors institutions are net BUYING into vs SELLING out of this quarter, with breadth (how many funds agree), net flow as % of the sector's book, and a rotation rank. Price-free, point-in-time, every number traced to 13F. Answers 'is smart money rotating out of tech into energy/utilities, and is it broad-based?' — what the sell-side ships as a static quarterly PDF. Pass `period` (ISO quarter-end) for a specific quarter, else the latest well-covered one. NOT investment advice; backward-looking (13F lags ~45 days).get_smart_money_leaderboard5 crWHO is the smart money? Ranks institutional funds by a PRICE-FREE quality score (concentration, selectivity, AUM growth, insider co-buy) — a concentrated conviction manager scores high, a 4,000-name index fund or market-maker scores low. Each fund comes with its full component breakdown (transparent, not a black box) AND its top NEW/ADDED positions this quarter — i.e. what the highest-CONVICTION money is newly buying. (Score is a price-free conviction proxy, NOT realized track record/performance. Operating-company 13F filers are excluded.) Sort by overall score, conviction, insider corroboration, or AUM growth. PRICE-FREE; NOT investment advice.get_ticker_confluence10 crFor ONE ticker: do the independent disclosure sources AGREE? Returns the cross-source confluence verdict — institutions (13F) × insiders (Form 4) × Congress (STOCK Act) all buying/selling the same name — PLUS the capital-rotation context: which sector the ticker is in and whether smart money is rotating INTO or OUT of that sector this quarter. The two flagship signals on one name. Congress is a free corroborating leg (never the sole basis). PRICE-FREE; NOT investment advice.

Funds & holdings (13F)#

Copy trading#

Insider trades (Form 4)#

Congress (STOCK Act)#

FDA & biotech catalysts#

clinicaltrials.search2 crUpcoming clinical-trial readout catalysts. For an industry-sponsored interventional Phase 2/3 drug trial, an ESTIMATED primaryCompletionDate is the expected topline-readout date — the binary event that re-rates a biotech ticker. Filter by sponsor (lead sponsor, INDUSTRY class), condition, phase, and a readout-date window; sorted soonest-first. Returns NCT id, title, phase, status, lead sponsor + resolved ticker (null if private/foreign), conditions, primary completion date (+ ACTUAL/ESTIMATED), and a study URL. CAVEAT: estimated dates are sponsor-self-reported and SLIP often — a readout WINDOW, not a hard date; press releases beat this feed. Public-domain ClinicalTrials.gov v2.fda.approvals2 crFDA drug-approval / rejection actions (Drugs@FDA, CDER). For a sponsor or drug, returns the regulatory action history: action=approved (AP, bullish), complete_response_letter (CR, a rejection — sharply bearish), or tentative_approval (TA). Flags new molecular entities (NME) and priority review — the highest-value catalysts. Resolves sponsor_name to a ticker (null if private). CAVEAT: backward-looking (records actions AFTER they happen, lags days; press releases beat it) — a confirmation/archive feed. Drugs@FDA is CDER-only, so biologics/vaccines (e.g. Moderna) may be absent. Public-domain openFDA.fda.recalls2 crFDA drug recalls (Recall Enterprise System). Class I = could cause death/serious harm (material adverse event); Class II/III lower. Filter by recalling firm, drug, classification, and recency; returns classification, reason, status, dates, and the recalling firm's resolved ticker (null if private). CAVEAT: enforcement data updates only WEEKLY and FDA does not revise recall status after classification — can be stale/frozen; not for real-time alerting. Public-domain openFDA.pharma.resolve1 crResolve a pharma sponsor / manufacturer name (e.g. 'Janssen Pharms', 'AstraZeneca AB') to its public ticker, so an FDA approval / trial readout / recall can be joined to 13F ownership, insider (Form 4) buys, and the confluence signal. Returns ticker, company name, exchange, and resolution method (alias|exact|fuzzy|unresolved). Returns ticker:null for private sponsors or unmatched names rather than guessing — joins must never key on a wrong ticker.

Filings & watchlist#

Signals & cross-source joins#

Prediction markets#

Macro (FRED)#

Search & provenance#

Account (free)#